Endoscopic Cauterization for GERD Valve Formation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for gastroesophageal reflux disease (GERD) either require long-term oral medication with uncertain symptom improvement or invasive surgical procedures, and existing endoscopic treatments involve mucous membrane resection which is not always effective or minimally invasive.
Innovation Solution
An endoscopic treatment method involving the insertion of an endoscope to form a damaged area in the digestive tract by cauterizing the mucosal base layer without excising the mucous membrane, creating an incomplete stenosis to reduce reflux, using a treatment tool to mark and swell the mucosal areas, and applying controlled cauterization to form scarring that reduces reflux without excising tissue.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If oral treatment with gastric acid secretion inhibitor is used, then treatment can be administered non-invasively, but long-term administration is required and symptoms may not improve
Solution Approach 1:
The patent replaces the pharmacological approach (oral medication) with a physical/endoscopic approach (cauterization and tissue remodeling). The endoscopic treatment uses mechanical energy (electrosurgical current) to create controlled thermal damage that leads to permanent anatomical changes, substituting long-term chemical suppression with a single or limited series of procedural interventions.
2Reliability
If surgical treatment such as laparoscopic Nissen fundoplication is used, then the problem can be solved effectively, but the treatment is highly invasive
Solution Approach 1:
The patent extracts the essential therapeutic effect of surgical fundoplication (creating a valve mechanism to prevent reflux) but achieves it through endoscopic mucosal cauterization rather than surgical dissection and wrapping. The procedure removes the need for invasive surgical manipulation by using controlled thermal injury to the mucosa to achieve similar functional outcomes.
Solution Approach 2:
The patent introduces scar tissue formation as an intermediary mechanism that mediates between the applied thermal energy and the desired anti-reflux effect. The controlled scarring process creates tissue thickening and stiffness that mechanically prevents gastric contents from refluxing, serving as an intermediate step between cauterization and the final therapeutic outcome.
3Reliability
If existing endoscopic treatment resecting mucous membrane is used, then reflux can be suppressed, but the treatment is not always effective and may not be minimally invasive
Solution Approach 1:
The patent applies cauterization to specific localized areas of the mucosa rather than performing circumferential resection. By targeting specific zones with controlled thermal energy, the treatment creates focal areas of scarring that are sufficient to prevent reflux while preserving the overall integrity and minimal invasiveness of the endoscopic approach.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method provides a minimally invasive treatment for GERD that effectively reduces reflux symptoms by forming a valve-like structure at the gastroesophageal junction, minimizing the risk of complications such as perforation or bleeding, and allowing for flexible follow-up treatments as needed.
Implementation Method 1
observing with the endoscope
Implementation Method 2
forming a damaged area in at least a portion of the digestive tract along a circumferential direction by performing cauterizing
Data Source
AI summary
An endoscopic treatment method includes: inserting an endoscope into a digestive tract; forming a damaged area in at least a portion of the digestive tract along a circumferential direction by performing cauterizing while keeping a mucosal layer by observing with the endoscope; and forming an incomplete stenosis in the digestive tract, while restoring the damaged area, wherein the damaged area is formed by causing damage to a mucosal base layer, the mucosal base layer having an interface that contacts a submucosal layer.